Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  

Jim Hoffman

Jim Hoffman: Could Targeting NETosis Reduce Long-Term Risk After STEMI?
Aug 24, 2026, 15:15 | Science
Jim Hoffman: Could Targeting NETosis Reduce Long-Term Risk After STEMI?
Jim Hoffman, Independent Consultant, shared a post on LinkedIn about recent articles, adding: "ST-elevation myocardial…
Jim Hoffman: NETs in STEMI and Their Association With PCI and Antithrombotic Treatments
Aug 23, 2026, 16:01 | Science
Jim Hoffman: NETs in STEMI and Their Association With PCI and Antithrombotic Treatments
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, shared a post on X about…
Jim Hoffman: Autoimmune Disease Masquerading as Schizophrenia
Jul 31, 2026, 16:14 | Science
Jim Hoffman: Autoimmune Disease Masquerading as Schizophrenia
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, shared Brain Inflammation Collaborative's post on…
Jim Hoffman: Separating Evidence from Misinformation on Vaccine-Associated Thrombosis
Jul 21, 2026, 12:34 | Science
Jim Hoffman: Separating Evidence from Misinformation on Vaccine-Associated Thrombosis
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, shared Jocelyn M.'s post on LinkedIn,…
Jim Hoffman: Targeting NETosis to Restore Immune Homeostasis
Jul 7, 2026, 17:25 | Science
Jim Hoffman: Targeting NETosis to Restore Immune Homeostasis
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, shared a post on LinkedIn: "True,…
Jim Hoffman: Lupus Treatment Must Balance Disease Control with Long-Term Safety
Jul 4, 2026, 13:32 | Science
Jim Hoffman: Lupus Treatment Must Balance Disease Control with Long-Term Safety
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, shared a post on LinkedIn about…
Heghine Khachatryan: Emerging Evidence Links NET Formation to Thrombosis and Disease Progression in Gynecologic Malignancies
Jun 21, 2026, 07:39 | Science
Heghine Khachatryan: Emerging Evidence Links NET Formation to Thrombosis and Disease Progression in Gynecologic Malignancies
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology…
Jim Hoffman: A New Approach to Balancing Host Defense and Tissue Protection
May 22, 2026, 17:24 | Voices
Jim Hoffman: A New Approach to Balancing Host Defense and Tissue Protection
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, shared Nicole Malachowski ’s post on LinkedIn…
Jim Hoffman: Persistent EBV Infection and the Promise of NET-Targeted Treatment
May 12, 2026, 15:14 | Science
Jim Hoffman: Persistent EBV Infection and the Promise of NET-Targeted Treatment
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, shared Santersus AG's post on LinkedIn:…
Jim Hoffman: Thrombomodulin as a Key Regulator of Coagulation and Inflammation
May 8, 2026, 16:15 | Science
Jim Hoffman: Thrombomodulin as a Key Regulator of Coagulation and Inflammation
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, shared a post on LinkedIn about…
Nicolas Hubacz: Natural Killer Cells versus Cancer
Apr 30, 2026, 16:53 | Voices
Nicolas Hubacz: Natural Killer Cells versus Cancer
Nicolas Hubacz, Research and Clinical Products Business Development Manager at Magstim, shared a post on…
Jim Hoffman: Targeting NETosis and Microclotting to Restore Immune and Hemostatic Balance
Apr 21, 2026, 09:15 | Science
Jim Hoffman: Targeting NETosis and Microclotting to Restore Immune and Hemostatic Balance
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, shared Ronald Li’s post on LinkedIn,…
Jim Hoffman: Reversing Vascular Damage through NETosis Modulation and Efferocytosis Balance
Apr 18, 2026, 18:23 | Science
Jim Hoffman: Reversing Vascular Damage through NETosis Modulation and Efferocytosis Balance
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, shared Donna Morreli's post on LinkedIn:…
Jim Hoffman: Extracorporeal Blood Purification as an Alternative to IVIG and Transfusion in Autoimmune Disease
Apr 6, 2026, 16:17 | Science
Jim Hoffman: Extracorporeal Blood Purification as an Alternative to IVIG and Transfusion in Autoimmune Disease
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, shared a post on LinkedIn: "Due…
Jim Hoffman: Dysregulated NETosis as a Key Driver of Neuro–Cardiac–Metabolic Health Dysfunction
Apr 1, 2026, 11:36 | Science
Jim Hoffman: Dysregulated NETosis as a Key Driver of Neuro–Cardiac–Metabolic Health Dysfunction
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, shared Abhilasha Singh’s post on LinkedIn,…
Jim Hoffman: Does Multiomics Suggest LC PASC Patients Require Multiple Drugs to Correct Biochemical Dysregulation?
Mar 31, 2026, 16:02 | Science
Jim Hoffman: Does Multiomics Suggest LC PASC Patients Require Multiple Drugs to Correct Biochemical Dysregulation?
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, shared Paul Watton’s post on LinkedIn, adding:…
Jim Hoffman։ Targeting NETosis to Help Autoimmune and Post-Infection Syndromes
Mar 30, 2026, 15:23 | Science
Jim Hoffman։ Targeting NETosis to Help Autoimmune and Post-Infection Syndromes
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, shared Robert Bransfield's post on LinkedIn,…
Jim Hoffman: NETosis Dysregulation Links Cancer Progression and Autoimmunity
Mar 28, 2026, 18:57 | Science
Jim Hoffman: NETosis Dysregulation Links Cancer Progression and Autoimmunity
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, posted on LinkedIn: "'These findings suggest that…
Jim Hoffman: Exploring Extracorporeal Strategies to Target NETs in Cardiovascular Disease
Mar 9, 2026, 15:25 | Science
Jim Hoffman: Exploring Extracorporeal Strategies to Target NETs in Cardiovascular Disease
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, shared Apherese ForschungsInstitut - AFI's post…
Jim Hoffman: Could Extracorporeal Removal of NETs Become a ‘Holy Grail’ Therapy Across Multiple Diseases?
Feb 28, 2026, 11:40 | Voices
Jim Hoffman: Could Extracorporeal Removal of NETs Become a ‘Holy Grail’ Therapy Across Multiple Diseases?
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, shared a post on LinkedIn about…
Jim Hoffman։ Targeting NETosis to Improve Perfusion and Reduce Thrombosis in AMI
Feb 26, 2026, 15:42 | Voices
Jim Hoffman։ Targeting NETosis to Improve Perfusion and Reduce Thrombosis in AMI
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, posted on LinkedIn about a recent article…
Paul Wischmeyer: Nutrient Absorption in the GI Tract
Feb 17, 2026, 15:42 | Voices
Paul Wischmeyer: Nutrient Absorption in the GI Tract
Paul Wischmeyer, Professor of Anesthesiology and Surgery with Tenure at Duke University School of Medicine, shared…
Jim Hoffman: Affinity-Based Blood Purification as a Potential Alternative to Plasma Exchange
Feb 9, 2026, 17:41 | Voices
Jim Hoffman: Affinity-Based Blood Purification as a Potential Alternative to Plasma Exchange
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, posted on LinkedIn: "A business model …
Jim Hoffman: Targeting Extracorporeal Removal of Extracellular Chromatin to Mitigate Lupus Pathogenesis
Feb 6, 2026, 18:42 | Science
Jim Hoffman: Targeting Extracorporeal Removal of Extracellular Chromatin to Mitigate Lupus Pathogenesis
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, posted on LinkedIn about a recent article…
Jim Hoffman on a Unifying Therapy: Extracorporeal NET Removal for Lupus and Autoimmune Organ Injury
Dec 28, 2025, 15:38 | Insight
Jim Hoffman on a Unifying Therapy: Extracorporeal NET Removal for Lupus and Autoimmune Organ Injury
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, posted on LinkedIn: "Chronic dysregulated NETosis…
Jim Hoffman: How Poor Efferocytosis Self-Sufficiency Causes Circulating Blood Levels of NETs Rising
Dec 27, 2025, 10:13 | Science
Jim Hoffman: How Poor Efferocytosis Self-Sufficiency Causes Circulating Blood Levels of NETs Rising
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, reposted Muhammad HARIS Baig on LinkedIn: "Poor…
Jim Hoffman on the Gut-Vascular Axis: How a Poor Diet Fuels NETosis and Immunothrombosis
Dec 26, 2025, 09:57 | Science
Jim Hoffman on the Gut-Vascular Axis: How a Poor Diet Fuels NETosis and Immunothrombosis
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, posted on LinkedIn: "A poor gut microbiome, nurtured…
Jim Hoffman: Why NET-Removing Blood Purification Should Be a First Resort, Not a Last
Dec 21, 2025, 06:54 | Science
Jim Hoffman: Why NET-Removing Blood Purification Should Be a First Resort, Not a Last
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, posted on LinkedIn: "We should be investigating blood…
Jim Hoffman: Uncontrolled Neutrophil Activation and NET Release in the Vasculature
Dec 17, 2025, 23:59 | Science
Jim Hoffman: Uncontrolled Neutrophil Activation and NET Release in the Vasculature
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, posted on LinkedIn: " 'We observe extensive spontaneous…
Jim Hoffman: Timely Extracorporeal NET Removal Therapy Should Be Tried on High-Risk Patients
Dec 16, 2025, 23:04 | Science
Jim Hoffman: Timely Extracorporeal NET Removal Therapy Should Be Tried on High-Risk Patients
Jim Hoffman, Technical Advisor at Cygnus Technologies, LLC, reposted  from  Jocelyn M. on LinkedIn: “We…
Biofilms, NETosis, and Microclots: Jim Hoffman Reflects on New Scientific Advances
Dec 12, 2025, 08:52 | Science
Biofilms, NETosis, and Microclots: Jim Hoffman Reflects on New Scientific Advances
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, posted on LinkedIn: '' 'Two key…
Jim Hoffman on a Critical Question: Should We Track NETosis and Use Blood Purification in Heart Failure?
Dec 1, 2025, 15:30 | Science
Jim Hoffman on a Critical Question: Should We Track NETosis and Use Blood Purification in Heart Failure?
Jim Hoffman, Technical Advisor at Cygnus Technologies, LLC, reposted Shashikant R Iyengar's post on LinkedIn: "Do…
All: 32 Posts: 1 - 100
NewsFeed